- Home
- JANX vs MRX Comparison
JANX vs MRX Comparison
Compare JANX & MRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- MRX
- Stock Information
- Founded
- JANX 2017
- MRX 2005
- Country
- JANX United States
- MRX United Kingdom
- Employees
- JANX N/A
- MRX N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- MRX
- Sector
- JANX Health Care
- MRX
- Exchange
- JANX Nasdaq
- MRX NYSE
- Market Cap
- JANX 2.2B
- MRX 2.5B
- IPO Year
- JANX 2021
- MRX 2024
- Fundamental
- Price
- JANX $36.01
- MRX $37.03
- Analyst Decision
- JANX Strong Buy
- MRX Strong Buy
- Analyst Count
- JANX 11
- MRX 8
- Target Price
- JANX $83.09
- MRX $33.25
- AVG Volume (30 Days)
- JANX 821.6K
- MRX 360.9K
- Earning Date
- JANX 03-07-2025
- MRX 03-06-2025
- Dividend Yield
- JANX N/A
- MRX 0.75%
- EPS Growth
- JANX N/A
- MRX 2.80
- EPS
- JANX N/A
- MRX 2.51
- Revenue
- JANX $13,049,000.00
- MRX $1,539,450,000.00
- Revenue This Year
- JANX $39.66
- MRX N/A
- Revenue Next Year
- JANX N/A
- MRX $6.17
- P/E Ratio
- JANX N/A
- MRX $14.84
- Revenue Growth
- JANX 54.12
- MRX N/A
- 52 Week Low
- JANX $14.68
- MRX $18.13
- 52 Week High
- JANX $71.71
- MRX $40.05
- Technical
- Relative Strength Index (RSI)
- JANX 34.78
- MRX N/A
- Support Level
- JANX $36.13
- MRX N/A
- Resistance Level
- JANX $38.13
- MRX N/A
- Average True Range (ATR)
- JANX 2.52
- MRX 0.00
- MACD
- JANX 0.08
- MRX 0.00
- Stochastic Oscillator
- JANX 5.71
- MRX 0.00
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About MRX MAREX GROUP PLC
Marex Group PLC is a company that offers a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. It provides critical services to the clients by connecting them to global exchanges and providing a range of execution and hedging services across a range of its asset and products. They operate in a large and fragmented market with significant infrastructure requirements and regulatory and technological complexity, resulting in high barriers to entry.